Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DISHMAN PHARMA   MYLAN
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
MYLAN
Dec-18
DISHMAN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3743,975-   
Low Rs1292,188-   
Sales per share (Unadj.) Rs197.01,829.1-  
Earnings per share (Unadj.) Rs21.249.7-  
Cash flow per share (Unadj.) Rs34.7392.1-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.91,978.8-  
Shares outstanding (eoy) m80.70514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 75.8%   
Avg P/E ratio x11.962.0 19.1%  
P/CF ratio (eoy) x7.37.9 92.3%  
Price / Book Value ratio x1.41.6 89.8%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3071,585,442 1.3%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m5,3550-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m15,898941,074 1.7%  
Other income Rs m2650-   
Total revenues Rs m16,163941,074 1.7%   
Gross profit Rs m4,103243,515 1.7%  
Depreciation Rs m1,091176,206 0.6%   
Interest Rs m94445,262 2.1%   
Profit before tax Rs m2,33422,047 10.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-3,507 -17.8%   
Profit after tax Rs m1,71025,554 6.7%  
Gross profit margin %25.825.9 99.7%  
Effective tax rate %26.7-15.9 -168.0%   
Net profit margin %10.82.7 396.1%  
BALANCE SHEET DATA
Current assets Rs m11,018525,495 2.1%   
Current liabilities Rs m9,517383,144 2.5%   
Net working cap to sales %9.415.1 62.4%  
Current ratio x1.21.4 84.4%  
Inventory Days Days5784 68.2%  
Debtors Days Days393 3.7%  
Net fixed assets Rs m18,787182,553 10.3%   
Share capital Rs m161501 32.2%   
"Free" reserves Rs m14,3540-   
Net worth Rs m14,5161,018,070 1.4%   
Long term debt Rs m4,1891,098,825 0.4%   
Total assets Rs m29,8052,730,861 1.1%  
Interest coverage x3.51.5 233.4%   
Debt to equity ratio x0.31.1 26.7%  
Sales to assets ratio x0.50.3 154.8%   
Return on assets %8.92.6 343.4%  
Return on equity %11.82.5 469.3%  
Return on capital %17.53.2 551.2%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786195,555 1.4%  
From Investments Rs m-1,529-101,081 1.5%  
From Financial Activity Rs m-941-91,101 1.0%  
Net Cashflow Rs m3171,620 19.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare DISHMAN PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare DISHMAN PHARMA With: AVON ORGANIC  VALIANT LABORATORIES LTD.  SYNCOM FORMULATIONS  ADVIK LABORS  COLINZ LABOR  



Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.